Charak Center for Health and Wellness
1530 West River Road North, First Floor, Elyria
4.3(338 Google reviews)
United States
3 listed treatment centers serving Elyria and the surrounding area.
1530 West River Road North, First Floor, Elyria
4.3(338 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Elyria.
12.8 miles away · Westlake
12.8 miles away · Westlake
The cost of SPRAVATO® treatment for someone in Elyria depends on insurance benefits, the treatment setting, and how services are billed. Both the medication and the observed treatment and monitoring visit may generate charges. Ask for an estimate that separates these services and explains your potential deductible, copay, or coinsurance responsibilities.
Prior authorization is common. Your insurer may require the prescriber to submit records of earlier antidepressant trials before treatment starts. Ask which records are needed, including medication names, treatment dates, doses, and responses. If previous care took place elsewhere, arranging a records transfer early may help avoid administrative delays. Authorization does not necessarily mean every charge will be paid.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Ohio Medicaid coverage also depends on the plan and applicable requirements. The three Elyria listings in this directory indicate that they do not accept Medicare or Medicaid; confirm current information directly before scheduling. A program's potential coverage is different from a particular center's willingness to bill it.
Manufacturer savings programs exist for eligible commercially insured patients, not patients using government insurance. Eligibility and program terms must be checked; assistance should not be assumed.
Before starting, ask the center and insurer:
SPRAVATO® is given only in a healthcare setting certified through the Spravato REMS safety program. You self-administer the nasal spray under direct observation; it is never sent home. This directory lists three Elyria centers offering treatment, but their REMS certification status is not documented here. Confirm certification directly before arranging care.
For treatment-resistant depression, the typical labeled schedule begins with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the appropriate schedule; do not assume a fixed long-term visit frequency.
Reserve more than a two-hour window. Monitoring alone lasts at least two hours after each dose, and check-in, preparation, or a need for longer observation can add time. Ask the center when you should arrive and how it decides you are ready to leave.
You need someone else to take you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange a reliable driver and a backup, and check the center's transportation policy before relying on a hired ride. Plan time away from work, childcare, and other responsibilities, particularly during the initial twice-weekly phase.
If no Elyria center is listed when you search, or local appointments are unavailable, you can investigate listings in Strongsville, Cleveland, or Akron. These listings do not establish certification, appointment availability, or insurance acceptance. Confirm those details and a workable round-trip transportation plan before choosing a location.
This directory lists three Elyria centers offering Spravato, but their REMS certification status is not documented here. Ask each center to confirm that the location where you would receive treatment is currently REMS-certified. Also check whether it accepts new patients, requires a referral, and works with your insurance before scheduling an evaluation.
Spravato is approved for adults with treatment-resistant depression, alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your diagnosis, treatment history, and safety considerations to determine whether it is appropriate.
Coverage depends on your plan, treatment setting, and authorization requirements. Medicare Part B or Part D and Ohio Medicaid may cover treatment in some circumstances. However, the three Elyria listings indicate they do not accept Medicare or Medicaid. Confirm their current policies, and ask your plan about participating providers and coverage for both the medication and monitoring visit.
You use the nasal spray yourself under a healthcare provider's direct observation in a REMS-certified setting. Staff monitor you for at least two hours afterward, including checks for blood pressure increases, sedation, dissociation, and breathing problems. You may need longer observation. Someone else must take you home, and you cannot drive until the next day after a restful sleep.
Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. Blood pressure can also rise. Dissociation can feel like being disconnected from yourself or your surroundings. Spravato is a Schedule III controlled substance. Discuss your medical history, medications, and substance-use history so the clinician can assess risks and explain monitoring.
Do not wait for a treatment appointment to seek urgent help. In a crisis, call or text 988; call 911 for an immediate emergency. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior. Even when prescribed for depressive symptoms associated with acute suicidal ideation or behavior, it does not replace hospitalization when clinically needed.
Approved uses, nearby treatment centers, and medically sourced patient guides.